Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography

Joseph Tung Chieh Chang, Sheng Chieh Chan, Tzu Chen Yen, Chun Ta Liao, Chien Yu Lin, Kun Ju Lin, I. How Chen, Hung Ming Wang, Yu Chen Chang, Tsung-Ming Chen, Chung Jan Kang, Shu Hang Ng

Research output: Contribution to journalArticle

83 Citations (Scopus)

Abstract

Purpose: Nasopharyngeal carcinoma (NPC) has a high rate of neck lymph node and/or distant metastasis. We evaluated the value of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in staging NPC, especially in the detection of distant metastasis. Methods and Materials: A total of 95 patients, including 85 with primary and 10 with recurrent, NPC were enrolled. Dual-phase FDG-PET was used, in addition to the conventional workup. Eighty-one patients without distant metastases underwent repeat studies 3-4 months after initial radical treatment. Results: Of 14 patients with distant metastases, all had lesions detected by FDG-PET, and the conventional workup detected the metastases in only 4. Two patients had false-positive MRI findings for neck node metastasis, but the FDG-PET findings were accurate. Four patients without distant metastases on their initial workup were found to have new lesions on FDG-PET 3-4 months after initial treatment. Patients with advanced node disease had a significantly greater incidence of distant metastases on FDG-PET, especially for N3 disease. Of the 95 patients, the FDG-PET results for distant metastasis were true positive in 14 patients, false positive in 8, and true negative in 73. None of our patients had a false-negative result. For a patient base, the sensitivity and specificity of FDG-PET for distant metastasis was 100% and 90.1% (95% confidence interval 81.5-95.6%), respectively, in this study. The accuracy was 91.6% (95% confidence interval 84.1-96.3%), the positive predictive value was 63.6 (95% confidence interval 40.7-82.8%), and the negative predictive value was 100%. Conclusion: FDG-PET stages N and M disease of NPC more accurately and sensitively than does the conventional workup. Patients with advanced node disease, particularly N3 disease, would benefit the most from FDG-PET.

Original languageEnglish
Pages (from-to)501-507
Number of pages7
JournalInternational Journal of Radiation Oncology Biology Physics
Volume62
Issue number2
DOIs
Publication statusPublished - Jun 1 2005
Externally publishedYes

Fingerprint

Fluorodeoxyglucose F18
metastasis
Positron-Emission Tomography
positrons
tomography
cancer
Neoplasm Metastasis
confidence
Confidence Intervals
intervals
lesions
Nasopharyngeal carcinoma
Neck
lymphatic system
incidence
Lymph Nodes
Sensitivity and Specificity

Keywords

  • Conventional workup
  • FDG-PET
  • Metastases
  • Nasopharyngeal carcinoma
  • TNM staging

ASJC Scopus subject areas

  • Radiation
  • Oncology
  • Radiology Nuclear Medicine and imaging
  • Cancer Research

Cite this

Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. / Chang, Joseph Tung Chieh; Chan, Sheng Chieh; Yen, Tzu Chen; Liao, Chun Ta; Lin, Chien Yu; Lin, Kun Ju; Chen, I. How; Wang, Hung Ming; Chang, Yu Chen; Chen, Tsung-Ming; Kang, Chung Jan; Ng, Shu Hang.

In: International Journal of Radiation Oncology Biology Physics, Vol. 62, No. 2, 01.06.2005, p. 501-507.

Research output: Contribution to journalArticle

Chang, JTC, Chan, SC, Yen, TC, Liao, CT, Lin, CY, Lin, KJ, Chen, IH, Wang, HM, Chang, YC, Chen, T-M, Kang, CJ & Ng, SH 2005, 'Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography', International Journal of Radiation Oncology Biology Physics, vol. 62, no. 2, pp. 501-507. https://doi.org/10.1016/j.ijrobp.2004.09.057
Chang, Joseph Tung Chieh ; Chan, Sheng Chieh ; Yen, Tzu Chen ; Liao, Chun Ta ; Lin, Chien Yu ; Lin, Kun Ju ; Chen, I. How ; Wang, Hung Ming ; Chang, Yu Chen ; Chen, Tsung-Ming ; Kang, Chung Jan ; Ng, Shu Hang. / Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography. In: International Journal of Radiation Oncology Biology Physics. 2005 ; Vol. 62, No. 2. pp. 501-507.
@article{27b53b4bdb304e2c88ed1ff6168c7bbf,
title = "Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography",
abstract = "Purpose: Nasopharyngeal carcinoma (NPC) has a high rate of neck lymph node and/or distant metastasis. We evaluated the value of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in staging NPC, especially in the detection of distant metastasis. Methods and Materials: A total of 95 patients, including 85 with primary and 10 with recurrent, NPC were enrolled. Dual-phase FDG-PET was used, in addition to the conventional workup. Eighty-one patients without distant metastases underwent repeat studies 3-4 months after initial radical treatment. Results: Of 14 patients with distant metastases, all had lesions detected by FDG-PET, and the conventional workup detected the metastases in only 4. Two patients had false-positive MRI findings for neck node metastasis, but the FDG-PET findings were accurate. Four patients without distant metastases on their initial workup were found to have new lesions on FDG-PET 3-4 months after initial treatment. Patients with advanced node disease had a significantly greater incidence of distant metastases on FDG-PET, especially for N3 disease. Of the 95 patients, the FDG-PET results for distant metastasis were true positive in 14 patients, false positive in 8, and true negative in 73. None of our patients had a false-negative result. For a patient base, the sensitivity and specificity of FDG-PET for distant metastasis was 100{\%} and 90.1{\%} (95{\%} confidence interval 81.5-95.6{\%}), respectively, in this study. The accuracy was 91.6{\%} (95{\%} confidence interval 84.1-96.3{\%}), the positive predictive value was 63.6 (95{\%} confidence interval 40.7-82.8{\%}), and the negative predictive value was 100{\%}. Conclusion: FDG-PET stages N and M disease of NPC more accurately and sensitively than does the conventional workup. Patients with advanced node disease, particularly N3 disease, would benefit the most from FDG-PET.",
keywords = "Conventional workup, FDG-PET, Metastases, Nasopharyngeal carcinoma, TNM staging",
author = "Chang, {Joseph Tung Chieh} and Chan, {Sheng Chieh} and Yen, {Tzu Chen} and Liao, {Chun Ta} and Lin, {Chien Yu} and Lin, {Kun Ju} and Chen, {I. How} and Wang, {Hung Ming} and Chang, {Yu Chen} and Tsung-Ming Chen and Kang, {Chung Jan} and Ng, {Shu Hang}",
year = "2005",
month = "6",
day = "1",
doi = "10.1016/j.ijrobp.2004.09.057",
language = "English",
volume = "62",
pages = "501--507",
journal = "International Journal of Radiation Oncology Biology Physics",
issn = "0360-3016",
publisher = "Elsevier Inc.",
number = "2",

}

TY - JOUR

T1 - Nasopharyngeal carcinoma staging by (18)F-fluorodeoxyglucose positron emission tomography

AU - Chang, Joseph Tung Chieh

AU - Chan, Sheng Chieh

AU - Yen, Tzu Chen

AU - Liao, Chun Ta

AU - Lin, Chien Yu

AU - Lin, Kun Ju

AU - Chen, I. How

AU - Wang, Hung Ming

AU - Chang, Yu Chen

AU - Chen, Tsung-Ming

AU - Kang, Chung Jan

AU - Ng, Shu Hang

PY - 2005/6/1

Y1 - 2005/6/1

N2 - Purpose: Nasopharyngeal carcinoma (NPC) has a high rate of neck lymph node and/or distant metastasis. We evaluated the value of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in staging NPC, especially in the detection of distant metastasis. Methods and Materials: A total of 95 patients, including 85 with primary and 10 with recurrent, NPC were enrolled. Dual-phase FDG-PET was used, in addition to the conventional workup. Eighty-one patients without distant metastases underwent repeat studies 3-4 months after initial radical treatment. Results: Of 14 patients with distant metastases, all had lesions detected by FDG-PET, and the conventional workup detected the metastases in only 4. Two patients had false-positive MRI findings for neck node metastasis, but the FDG-PET findings were accurate. Four patients without distant metastases on their initial workup were found to have new lesions on FDG-PET 3-4 months after initial treatment. Patients with advanced node disease had a significantly greater incidence of distant metastases on FDG-PET, especially for N3 disease. Of the 95 patients, the FDG-PET results for distant metastasis were true positive in 14 patients, false positive in 8, and true negative in 73. None of our patients had a false-negative result. For a patient base, the sensitivity and specificity of FDG-PET for distant metastasis was 100% and 90.1% (95% confidence interval 81.5-95.6%), respectively, in this study. The accuracy was 91.6% (95% confidence interval 84.1-96.3%), the positive predictive value was 63.6 (95% confidence interval 40.7-82.8%), and the negative predictive value was 100%. Conclusion: FDG-PET stages N and M disease of NPC more accurately and sensitively than does the conventional workup. Patients with advanced node disease, particularly N3 disease, would benefit the most from FDG-PET.

AB - Purpose: Nasopharyngeal carcinoma (NPC) has a high rate of neck lymph node and/or distant metastasis. We evaluated the value of (18)F-fluorodeoxyglucose positron emission tomography (FDG-PET) in staging NPC, especially in the detection of distant metastasis. Methods and Materials: A total of 95 patients, including 85 with primary and 10 with recurrent, NPC were enrolled. Dual-phase FDG-PET was used, in addition to the conventional workup. Eighty-one patients without distant metastases underwent repeat studies 3-4 months after initial radical treatment. Results: Of 14 patients with distant metastases, all had lesions detected by FDG-PET, and the conventional workup detected the metastases in only 4. Two patients had false-positive MRI findings for neck node metastasis, but the FDG-PET findings were accurate. Four patients without distant metastases on their initial workup were found to have new lesions on FDG-PET 3-4 months after initial treatment. Patients with advanced node disease had a significantly greater incidence of distant metastases on FDG-PET, especially for N3 disease. Of the 95 patients, the FDG-PET results for distant metastasis were true positive in 14 patients, false positive in 8, and true negative in 73. None of our patients had a false-negative result. For a patient base, the sensitivity and specificity of FDG-PET for distant metastasis was 100% and 90.1% (95% confidence interval 81.5-95.6%), respectively, in this study. The accuracy was 91.6% (95% confidence interval 84.1-96.3%), the positive predictive value was 63.6 (95% confidence interval 40.7-82.8%), and the negative predictive value was 100%. Conclusion: FDG-PET stages N and M disease of NPC more accurately and sensitively than does the conventional workup. Patients with advanced node disease, particularly N3 disease, would benefit the most from FDG-PET.

KW - Conventional workup

KW - FDG-PET

KW - Metastases

KW - Nasopharyngeal carcinoma

KW - TNM staging

UR - http://www.scopus.com/inward/record.url?scp=18944376919&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=18944376919&partnerID=8YFLogxK

U2 - 10.1016/j.ijrobp.2004.09.057

DO - 10.1016/j.ijrobp.2004.09.057

M3 - Article

C2 - 15890593

AN - SCOPUS:18944376919

VL - 62

SP - 501

EP - 507

JO - International Journal of Radiation Oncology Biology Physics

JF - International Journal of Radiation Oncology Biology Physics

SN - 0360-3016

IS - 2

ER -